Tobacco Use in Pregnancy Intervention for Cessation (ToPIC)
調査の概要
詳細な説明
The purpose of this pilot project is to test effectiveness of a tobacco-treatment cessation intervention (American College of Obstetricians and Gynecologists (ACOG) 5 A's) through use of a non-physician healthcare champion from within the clinic's existing infrastructure. This Tobacco use in Pregnancy Intervention for Cessation (ToPIC) will involve training the identified healthcare provider to become a Certified Tobacco Treatment Specialist (CTTS) and to administer the 5 A's to pregnant Medicaid patients receiving prenatal care through two high-volume Kentucky obstetrics clinics. This trial will provide evidence to evaluate this approach to delivering an established intervention in clinical practice.
The Investigators propose to test the effectiveness of the clinical intervention by using a two-armed cluster randomized controlled design. Eligible participants will be randomized to the intervention (ToPIC) or standard of care for smoking cessation in pregnancy. This pilot project will gather quantitative and qualitative data for a mixed-method, multi-stakeholder process evaluation of intervention training and delivery. Furthermore, the Investigators' use of Medicaid claims data to examine healthcare utilization outside of maternal and infant well-care visits will enhance understanding of the strengths and limitations of these data for future evaluations. This study has the potential to significantly impact the most vulnerable in Kentucky, where rates of tobacco use among pregnant women are among the highest in the nation.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Kentucky
-
Lexington、Kentucky、アメリカ、40536
- University of Kentucky College of Nursing
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- pregnant
- tobacco user
- able to read and write English
- Medicaid eligible
Exclusion Criteria:
- male
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ：Tobacco Treatment As Usual (TTAU)
Eligible women assigned to the control group will be informed of the risks of tobacco use and benefits of quitting using the ACOG 5A's approach by their healthcare provider.5
This standard takes approximately 5-15 minutes, and is offered at each prenatal and postpartum appointment.
The study coordinator will invite participants to complete the tobacco use questionnaires (TUQ),urine cotinine validation, and Expired Air Carbon Monoxide (EACO) analysis to assess ongoing tobacco use at the designated time points.
|
Standard of care tobacco cessation counseling for pregnant women
|
|
実験的：ToPIC
Eligible women assigned to the intervention will receive TTAU plus ToPIC administered by the CTTS.
At least once monthly, at routinely scheduled prenatal visits or through telephone, the CTTS will provide cessation counseling.
The CTTS will invite participants to complete TUQs,urine cotinine validation and EACO analysis to assess ongoing tobacco use at the designated time points.
|
Expanded tobacco cessation counseling for pregnant women.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Smoking cessation
時間枠：Baseline to third trimester
|
Change in urine cotinine level
|
Baseline to third trimester
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Number of cigarettes per day
時間枠：Baseline to third trimester
|
Self-reported change in number of cigarettes smoked per day
|
Baseline to third trimester
|
|
Smoking cessation after delivery
時間枠：Prior to delivery hospitalization discharge, estimated 3 days
|
Self-report smoking cessation
|
Prior to delivery hospitalization discharge, estimated 3 days
|
|
Infant birth weight
時間枠：At time of delivery
|
Infant weight measured in grams
|
At time of delivery
|
|
Gestational age
時間枠：At time of delivery
|
Weeks of gestation at delivery
|
At time of delivery
|
|
Health care utilization outside of well-visits
時間枠：Birth to 6 months
|
Maternal and infant visits for non-routine healthcare
|
Birth to 6 months
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 17-0658-P3K
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
Tobacco Treatment As Usual (TTAU)の臨床試験
-
Massachusetts General HospitalNational Institutes of Health (NIH); Samaritans of Bostonまだ募集していません自殺念慮 | 自殺未遂 | 自殺